These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Lopalco G; Cantarini L; Vitale A; Iannone F; Anelli MG; Andreozzi L; Lapadula G; Galeazzi M; Rigante D Mediators Inflamm; 2015; 2015():194864. PubMed ID: 25784780 [TBL] [Abstract][Full Text] [Related]
23. Autoinflammation: Interferonopathies and Other Autoinflammatory Diseases. Savic S; Coe J; Laws P J Invest Dermatol; 2022 Mar; 142(3 Pt B):781-792. PubMed ID: 34887082 [TBL] [Abstract][Full Text] [Related]
24. No shortcuts: new findings reinforce why nuance is the rule in genetic autoinflammatory syndromes. Tsoukas P; Canna SW Curr Opin Rheumatol; 2017 Sep; 29(5):506-515. PubMed ID: 28604422 [TBL] [Abstract][Full Text] [Related]
25. Rare hereditary autoinflammatory disorders: towards an understanding of critical in vivo inflammatory pathways. Kanazawa N J Dermatol Sci; 2012 Jun; 66(3):183-9. PubMed ID: 22336993 [TBL] [Abstract][Full Text] [Related]
26. Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Goldbach-Mansky R Clin Exp Immunol; 2012 Mar; 167(3):391-404. PubMed ID: 22288582 [TBL] [Abstract][Full Text] [Related]
27. Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases. Lucherini OM; Rigante D; Sota J; Fabiani C; Obici L; Cattalini M; Gattorno M; Cantarini L Clin Exp Rheumatol; 2018; 36 Suppl 110(1):3-9. PubMed ID: 29742053 [TBL] [Abstract][Full Text] [Related]
28. Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers. Sharma M; Ferguson PJ Curr Opin Rheumatol; 2013 Sep; 25(5):658-64. PubMed ID: 23917160 [TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. de Jesus AA; Canna SW; Liu Y; Goldbach-Mansky R Annu Rev Immunol; 2015; 33():823-74. PubMed ID: 25706096 [TBL] [Abstract][Full Text] [Related]
31. The role of cellular proteostasis in antitumor immunity. Mercier R; LaPointe P J Biol Chem; 2022 May; 298(5):101930. PubMed ID: 35421375 [TBL] [Abstract][Full Text] [Related]
32. Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood. Welzel T; Benseler SM; Kuemmerle-Deschner JB Front Immunol; 2021; 12():516427. PubMed ID: 33868220 [TBL] [Abstract][Full Text] [Related]